SCHEMBL28572005

SCHEMBL28572005

C[C@H](N[S+]([O-])C(C)(C)C)c1nc2ccc(F)cc2cc1OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
STAT3 P40763 2/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34
DHODH Q02127 1/20 0.34
MAPK13 O15264 1/20 0.34
MAPK12 P53778 1/20 0.34
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
PPIA P62937 1/20 0.33
CCNT1 O60563 2/20 0.33
CDK2 P24941 2/20 0.33
CDK9 P50750 2/20 0.33
CCNA2 P20248 1/20 0.33
CCNA1 P78396 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28572006 1.00 LMNA (0.41) LMNASTAT3HTTSMN1; SMN2POLB
SCHEMBL20067904 1.00 LMNA (0.41) LMNASTAT3HTTSMN1; SMN2POLB
SCHEMBL23383007 0.80 LMNA (0.37) LMNAMAPTL3MBTL1LRRK2KDM4E
SCHEMBL21514010 0.80 LMNA (0.37) LMNAMAPTL3MBTL1LRRK2KDM4E
SCHEMBL20067907 0.79 HTT (0.49) LMNASTAT3HTTSMN1; SMN2POLB
SCHEMBL28563970 0.79 HTT (0.49) LMNASTAT3HTTSMN1; SMN2POLB
SCHEMBL31167021 0.78 PDGFRB (0.41) STAT3HTTSMN1; SMN2MAPTPDGFRB
SCHEMBL20061330 0.78 BACE1 (0.34)
SCHEMBL17040912 0.75 KDM1A (0.41) LMNAHTTSMN1; SMN2MAPTPPIA
SCHEMBL18862530 0.75 KDM1A (0.41) LMNAHTTSMN1; SMN2MAPTPPIA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107690433-B Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating PI3 kinase-associated diseases comprising the same as active ingredient 韩国化学研究院 2021-04-09 CN disclosed